Kane Logo Cropped TransBG.png
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
July 11, 2024 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with...
Kane Logo Cropped TransBG.png
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
June 27, 2024 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of...
Kane Logo Cropped TransBG.png
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
June 25, 2024 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with...
Kane Logo Cropped TransBG.png
Kane Biotech Announces First Quarter 2024 Financial Results
May 23, 2024 16:15 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results. The...
Kane Logo Cropped TransBG.png
Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024
May 16, 2024 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech to Host Investor Webinar
April 16, 2024 09:15 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
April 15, 2024 09:15 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, April 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that, it has completed the sale of its interest in STEM Animal Health Inc. to...
Kane Logo Cropped TransBG.png
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
March 20, 2024 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, March 20, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announces today that it has extended the exclusivity period on...
Kane Logo Cropped TransBG.png
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
March 19, 2024 16:10 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, March 19, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Receives Offer for its Interest in STEM Animal Health
December 20, 2023 08:29 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on December 19, 2023, it signed a...